Skip to main content
NCBI home page
Heart logoLink to Heart
. 1997 Aug;78(2):110–116. doi: 10.1136/hrt.78.2.110

The phenotype/genotype relation and the current status of genetic screening in hypertrophic cardiomyopathy, Marfan syndrome, and the long QT syndrome.

J Burn 1, J Camm 1, M J Davies 1, L Peltonen 1, P J Schwartz 1, H Watkins 1
PMCID: PMC484888  PMID: 9326982

Full text

PDF
110

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Barhanin J., Lesage F., Guillemare E., Fink M., Lazdunski M., Romey G. K(V)LQT1 and lsK (minK) proteins associate to form the I(Ks) cardiac potassium current. Nature. 1996 Nov 7;384(6604):78–80. doi: 10.1038/384078a0. [DOI] [PubMed] [Google Scholar]
  2. Bennett P. B., Yazawa K., Makita N., George A. L., Jr Molecular mechanism for an inherited cardiac arrhythmia. Nature. 1995 Aug 24;376(6542):683–685. doi: 10.1038/376683a0. [DOI] [PubMed] [Google Scholar]
  3. Cecchi F., Olivotto I., Montereggi A., Santoro G., Dolara A., Maron B. J. Hypertrophic cardiomyopathy in Tuscany: clinical course and outcome in an unselected regional population. J Am Coll Cardiol. 1995 Nov 15;26(6):1529–1536. doi: 10.1016/0735-1097(95)00353-3. [DOI] [PubMed] [Google Scholar]
  4. Curran M. E., Splawski I., Timothy K. W., Vincent G. M., Green E. D., Keating M. T. A molecular basis for cardiac arrhythmia: HERG mutations cause long QT syndrome. Cell. 1995 Mar 10;80(5):795–803. doi: 10.1016/0092-8674(95)90358-5. [DOI] [PubMed] [Google Scholar]
  5. Davies M. J., McKenna W. J. Hypertrophic cardiomyopathy--pathology and pathogenesis. Histopathology. 1995 Jun;26(6):493–500. doi: 10.1111/j.1365-2559.1995.tb00267.x. [DOI] [PubMed] [Google Scholar]
  6. Dietz H. C., Pyeritz R. E. Mutations in the human gene for fibrillin-1 (FBN1) in the Marfan syndrome and related disorders. Hum Mol Genet. 1995;4(Spec No):1799–1809. doi: 10.1093/hmg/4.suppl_1.1799. [DOI] [PubMed] [Google Scholar]
  7. Dumaine R., Wang Q., Keating M. T., Hartmann H. A., Schwartz P. J., Brown A. M., Kirsch G. E. Multiple mechanisms of Na+ channel--linked long-QT syndrome. Circ Res. 1996 May;78(5):916–924. doi: 10.1161/01.res.78.5.916. [DOI] [PubMed] [Google Scholar]
  8. Harris R., Williamson P. Confidential enquiry into counselling for genetic disorders. J R Coll Physicians Lond. 1996 Jul-Aug;30(4):316–317. [PMC free article] [PubMed] [Google Scholar]
  9. Jiang C., Atkinson D., Towbin J. A., Splawski I., Lehmann M. H., Li H., Timothy K., Taggart R. T., Schwartz P. J., Vincent G. M. Two long QT syndrome loci map to chromosomes 3 and 7 with evidence for further heterogeneity. Nat Genet. 1994 Oct;8(2):141–147. doi: 10.1038/ng1094-141. [DOI] [PubMed] [Google Scholar]
  10. Kainulainen K., Karttunen L., Puhakka L., Sakai L., Peltonen L. Mutations in the fibrillin gene responsible for dominant ectopia lentis and neonatal Marfan syndrome. Nat Genet. 1994 Jan;6(1):64–69. doi: 10.1038/ng0194-64. [DOI] [PubMed] [Google Scholar]
  11. Kielty C. M., Phillips J. E., Child A. H., Pope F. M., Shuttleworth C. A. Fibrillin secretion and microfibril assembly by Marfan dermal fibroblasts. Matrix Biol. 1994 Mar;14(2):191–199. doi: 10.1016/0945-053x(94)90008-6. [DOI] [PubMed] [Google Scholar]
  12. Kielty C. M., Shuttleworth C. A. Abnormal fibrillin assembly by dermal fibroblasts from two patients with Marfan syndrome. J Cell Biol. 1994 Mar;124(6):997–1004. doi: 10.1083/jcb.124.6.997. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Lee B., Godfrey M., Vitale E., Hori H., Mattei M. G., Sarfarazi M., Tsipouras P., Ramirez F., Hollister D. W. Linkage of Marfan syndrome and a phenotypically related disorder to two different fibrillin genes. Nature. 1991 Jul 25;352(6333):330–334. doi: 10.1038/352330a0. [DOI] [PubMed] [Google Scholar]
  14. McKenna W. J., Oakley C. M., Krikler D. M., Goodwin J. F. Improved survival with amiodarone in patients with hypertrophic cardiomyopathy and ventricular tachycardia. Br Heart J. 1985 Apr;53(4):412–416. doi: 10.1136/hrt.53.4.412. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Moss A. J., Zareba W., Benhorin J., Locati E. H., Hall W. J., Robinson J. L., Schwartz P. J., Towbin J. A., Vincent G. M., Lehmann M. H. ECG T-wave patterns in genetically distinct forms of the hereditary long QT syndrome. Circulation. 1995 Nov 15;92(10):2929–2934. doi: 10.1161/01.cir.92.10.2929. [DOI] [PubMed] [Google Scholar]
  16. Pereira L., Levran O., Ramirez F., Lynch J. R., Sykes B., Pyeritz R. E., Dietz H. C. A molecular approach to the stratification of cardiovascular risk in families with Marfan's syndrome. N Engl J Med. 1994 Jul 21;331(3):148–153. doi: 10.1056/NEJM199407213310302. [DOI] [PubMed] [Google Scholar]
  17. Priori S. G., Napolitano C., Cantù F., Brown A. M., Schwartz P. J. Differential response to Na+ channel blockade, beta-adrenergic stimulation, and rapid pacing in a cellular model mimicking the SCN5A and HERG defects present in the long-QT syndrome. Circ Res. 1996 Jun;78(6):1009–1015. doi: 10.1161/01.res.78.6.1009. [DOI] [PubMed] [Google Scholar]
  18. Putnam E. A., Zhang H., Ramirez F., Milewicz D. M. Fibrillin-2 (FBN2) mutations result in the Marfan-like disorder, congenital contractural arachnodactyly. Nat Genet. 1995 Dec;11(4):456–458. doi: 10.1038/ng1295-456. [DOI] [PubMed] [Google Scholar]
  19. Roden D. M., Lazzara R., Rosen M., Schwartz P. J., Towbin J., Vincent G. M. Multiple mechanisms in the long-QT syndrome. Current knowledge, gaps, and future directions. The SADS Foundation Task Force on LQTS. Circulation. 1996 Oct 15;94(8):1996–2012. doi: 10.1161/01.cir.94.8.1996. [DOI] [PubMed] [Google Scholar]
  20. Sanguinetti M. C., Curran M. E., Spector P. S., Keating M. T. Spectrum of HERG K+-channel dysfunction in an inherited cardiac arrhythmia. Proc Natl Acad Sci U S A. 1996 Mar 5;93(5):2208–2212. doi: 10.1073/pnas.93.5.2208. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Sanguinetti M. C., Curran M. E., Zou A., Shen J., Spector P. S., Atkinson D. L., Keating M. T. Coassembly of K(V)LQT1 and minK (IsK) proteins to form cardiac I(Ks) potassium channel. Nature. 1996 Nov 7;384(6604):80–83. doi: 10.1038/384080a0. [DOI] [PubMed] [Google Scholar]
  22. Schott J. J., Charpentier F., Peltier S., Foley P., Drouin E., Bouhour J. B., Donnelly P., Vergnaud G., Bachner L., Moisan J. P. Mapping of a gene for long QT syndrome to chromosome 4q25-27. Am J Hum Genet. 1995 Nov;57(5):1114–1122. [PMC free article] [PubMed] [Google Scholar]
  23. Schwartz P. J., Locati E. H., Moss A. J., Crampton R. S., Trazzi R., Ruberti U. Left cardiac sympathetic denervation in the therapy of congenital long QT syndrome. A worldwide report. Circulation. 1991 Aug;84(2):503–511. doi: 10.1161/01.cir.84.2.503. [DOI] [PubMed] [Google Scholar]
  24. Schwartz P. J., Priori S. G., Locati E. H., Napolitano C., Cantù F., Towbin J. A., Keating M. T., Hammoude H., Brown A. M., Chen L. S. Long QT syndrome patients with mutations of the SCN5A and HERG genes have differential responses to Na+ channel blockade and to increases in heart rate. Implications for gene-specific therapy. Circulation. 1995 Dec 15;92(12):3381–3386. doi: 10.1161/01.cir.92.12.3381. [DOI] [PubMed] [Google Scholar]
  25. Sepp R., Severs N. J., Gourdie R. G. Altered patterns of cardiac intercellular junction distribution in hypertrophic cardiomyopathy. Heart. 1996 Nov;76(5):412–417. doi: 10.1136/hrt.76.5.412. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Spirito P., Rapezzi C., Autore C., Bruzzi P., Bellone P., Ortolani P., Fragola P. V., Chiarella F., Zoni-Berisso M., Branzi A. Prognosis of asymptomatic patients with hypertrophic cardiomyopathy and nonsustained ventricular tachycardia. Circulation. 1994 Dec;90(6):2743–2747. doi: 10.1161/01.cir.90.6.2743. [DOI] [PubMed] [Google Scholar]
  27. Thierfelder L., Watkins H., MacRae C., Lamas R., McKenna W., Vosberg H. P., Seidman J. G., Seidman C. E. Alpha-tropomyosin and cardiac troponin T mutations cause familial hypertrophic cardiomyopathy: a disease of the sarcomere. Cell. 1994 Jun 3;77(5):701–712. doi: 10.1016/0092-8674(94)90054-x. [DOI] [PubMed] [Google Scholar]
  28. Towbin J. A., Li H., Taggart R. T., Lehmann M. H., Schwartz P. J., Satler C. A., Ayyagari R., Robinson J. L., Moss A., Hejtmancik J. F. Evidence of genetic heterogeneity in Romano-Ward long QT syndrome. Analysis of 23 families. Circulation. 1994 Dec;90(6):2635–2644. doi: 10.1161/01.cir.90.6.2635. [DOI] [PubMed] [Google Scholar]
  29. Tsipouras P., Devereux R. B. Marfan syndrome: genetic basis and clinical manifestations. Semin Dermatol. 1993 Sep;12(3):219–228. [PubMed] [Google Scholar]
  30. Wang Q., Curran M. E., Splawski I., Burn T. C., Millholland J. M., VanRaay T. J., Shen J., Timothy K. W., Vincent G. M., de Jager T. Positional cloning of a novel potassium channel gene: KVLQT1 mutations cause cardiac arrhythmias. Nat Genet. 1996 Jan;12(1):17–23. doi: 10.1038/ng0196-17. [DOI] [PubMed] [Google Scholar]
  31. Wang Q., Shen J., Li Z., Timothy K., Vincent G. M., Priori S. G., Schwartz P. J., Keating M. T. Cardiac sodium channel mutations in patients with long QT syndrome, an inherited cardiac arrhythmia. Hum Mol Genet. 1995 Sep;4(9):1603–1607. doi: 10.1093/hmg/4.9.1603. [DOI] [PubMed] [Google Scholar]
  32. Wang Q., Shen J., Splawski I., Atkinson D., Li Z., Robinson J. L., Moss A. J., Towbin J. A., Keating M. T. SCN5A mutations associated with an inherited cardiac arrhythmia, long QT syndrome. Cell. 1995 Mar 10;80(5):805–811. doi: 10.1016/0092-8674(95)90359-3. [DOI] [PubMed] [Google Scholar]
  33. Watkins H., Conner D., Thierfelder L., Jarcho J. A., MacRae C., McKenna W. J., Maron B. J., Seidman J. G., Seidman C. E. Mutations in the cardiac myosin binding protein-C gene on chromosome 11 cause familial hypertrophic cardiomyopathy. Nat Genet. 1995 Dec;11(4):434–437. doi: 10.1038/ng1295-434. [DOI] [PubMed] [Google Scholar]
  34. Watkins H., McKenna W. J., Thierfelder L., Suk H. J., Anan R., O'Donoghue A., Spirito P., Matsumori A., Moravec C. S., Seidman J. G. Mutations in the genes for cardiac troponin T and alpha-tropomyosin in hypertrophic cardiomyopathy. N Engl J Med. 1995 Apr 20;332(16):1058–1064. doi: 10.1056/NEJM199504203321603. [DOI] [PubMed] [Google Scholar]
  35. Watkins H., Seidman J. G., Seidman C. E. Familial hypertrophic cardiomyopathy: a genetic model of cardiac hypertrophy. Hum Mol Genet. 1995;4(Spec No):1721–1727. doi: 10.1093/hmg/4.suppl_1.1721. [DOI] [PubMed] [Google Scholar]

Articles from Heart are provided here courtesy of BMJ Publishing Group

RESOURCES